RICHMOND, Va.--(BUSINESS WIRE)--Commonwealth Biotechnologies, Inc. (“CBI”) (CBTEQ.PK) announced today that the SEC filings purportedly submitted on behalf of CBI were unauthorized. Further, the filings were replete with factual errors, misleading comments and baseless allegations. As a result, Mr. Guo has been removed from the Board of Directors as Chairman and as a Director. More specifically:
